Pharmacokinetic and Pharmacodynamic Properties of Calaspargase Pegol Escherichia coli L-Asparaginase in the Treatment of Patients With Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Study AALL07P4

PURPOSE: Asparaginase is a critical agent used to treat acute lymphoblastic leukemia (ALL). Pegaspargase (SS-PEG), a pegylated form of Escherichia coli L-asparaginase with a succinimidyl succinate (SS) linker, is the first-line asparaginase product used in Children's Oncology Group (COG) ALL tr...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Clin Oncol
Glavni autori: Angiolillo, Anne L., Schore, Reuven J., Devidas, Meenakshi, Borowitz, Michael J., Carroll, Andrew J., Gastier-Foster, Julie M., Heerema, Nyla A., Keilani, Taha, Lane, Ashley R., Loh, Mignon L., Reaman, Gregory H., Adamson, Peter C., Wood, Brent, Wood, Charlotte, Zheng, Hao W., Raetz, Elizabeth A., Winick, Naomi J., Carroll, William L., Hunger, Stephen P.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Clinical Oncology 2014
Teme:
ORIGINAL REPORTS
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4239306/
https://ncbi.nlm.nih.gov/pubmed/25348002
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.55.5763
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items